1. Home
  2. MOGO vs PMN Comparison

MOGO vs PMN Comparison

Compare MOGO & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mogo Inc.

MOGO

Mogo Inc.

HOLD

Current Price

$1.06

Market Cap

27.6M

Sector

N/A

ML Signal

HOLD

Logo ProMIS Neurosciences Inc. (ON)

PMN

ProMIS Neurosciences Inc. (ON)

HOLD

Current Price

$7.95

Market Cap

23.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOGO
PMN
Founded
2003
2004
Country
Canada
Canada
Employees
N/A
N/A
Industry
Pharmaceuticals and Biotechnology
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.6M
23.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
MOGO
PMN
Price
$1.06
$7.95
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$4.00
$72.67
AVG Volume (30 Days)
107.3K
31.5K
Earning Date
11-07-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.22
N/A
Revenue
$29,215,516.00
N/A
Revenue This Year
$63.05
N/A
Revenue Next Year
$5.58
N/A
P/E Ratio
$4.86
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.74
$6.27
52 Week High
$3.83
$39.75

Technical Indicators

Market Signals
Indicator
MOGO
PMN
Relative Strength Index (RSI) 32.09 62.68
Support Level $1.09 $8.00
Resistance Level $1.15 $8.73
Average True Range (ATR) 0.05 0.57
MACD 0.01 -0.33
Stochastic Oscillator 12.50 3.33

Price Performance

Historical Comparison
MOGO
PMN

About MOGO Mogo Inc.

Mogo Inc is a Canadian-based financial technology company. It offers a finance application to consumers with solutions that help them to control their financial health. At Mogo, users can sign up for a free account and get access to products and solutions that help users to monitor their credit score, protect themselves from identity fraud, control their spending, and borrow responsibly. Company offers digital loans and mortgages and also offer a digital payments platform that powers next-generation card programs for both established world-wide corporations and fintech companies in Europe and Canada.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS), and multiple system atrophy (MSA). The company applies its thermodynamic, computational discovery platform, ProMIS, and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: